MYC and plasma cell myeloma: This lncRNA interacts with the c-Myc factor and enhances its stimulatory effect on the glucose-6-phosphate dehydrogenase gene promoter (Figure 4), high levels of which allow for reducing the toxic effect of bortezomib on myeloma cells [56].